Company profile: S-Biomedic
1.1 - Company Overview
Company description
- Provider of skin microbiome therapeutic solutions using targeted modulation-based technology, offering Living Skin Probiotics (Cutibacterium) to aid recovery of a healthy microbiome, Sencyr Microbiome Care for acne-prone skin, CutiNaturalis Probiotic to restore microbiome balance, proprietary Modulation Technology to restore beneficial bacteria, and Living Skin Postbiotics from skin commensals.
Products and services
- Modulation Technology: Proprietary platform that restores beneficial bacteria on the skin to rebalance the microbiome and support healthy skin homeostasis through modulation of microbial communities
- Living Skin Probiotics: Cutibacterium-derived, living probiotic assemblies colonize the skin, aiding recovery of a healthy microbiome and supporting skin health by maintaining beneficial bacterial balance
- Sencyr Microbiome Care: Microbiome-driven skincare program utilizes skin microbiome technology to address acne-prone skin by supporting recovery of a healthy skin microbiome and promoting balanced bacterial communities
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to S-Biomedic
Ncardia
HQ: The Netherlands
Website
- Description: Provider of iPSC-based drug discovery platforms and predictive human cellular assay systems to expedite drug discovery from hit identification to lead optimization. Offers Ncyte Smooth Muscle Cells, Astrocytes, Endothelial Cells, Neural Mix, and vCardiomyocytes for in vitro modeling, safety and efficacy testing, cardiovascular and neural screening, pharmacology, toxicity, electrophysiology, and disease modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ncardia company profile →
Fluorogenics
HQ: United Kingdom
Website
- Description: Provider of cutting-edge sample-to-result integrated analyzers and real-time PCR lyophilized reagents, bringing technical expertise to these solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluorogenics company profile →
LI-COR
HQ: United States
Website
- Description: Provider of highly engineered instrumentation systems, analysis software, and reagents for environmental and plant research, gas analysis, agriculture, drug discovery, protein research, and small animal imaging; used in more than 100 countries and on the International Space Station.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LI-COR company profile →
Silicon Biosystems
HQ: Italy
Website
- Description: Provider of lab-on-a-chip technologies for miniaturized cell-biology testing, including SmartSlide for enrichment and label-free separation, DEPArray for image-based cell sorting and single-cell isolation, CELLSEARCH tests for circulating tumor cells and multiple myeloma, CellMag products for immunomagnetic enrichment and staining, and Ampli1 kits for single-cell DNA analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Silicon Biosystems company profile →
CrestOptics
HQ: Italy
Website
- Description: Provider of advanced fluorescence microscopy systems and modules, including CICERO widefield and spinning disk confocal for inverted/upright setups with wide spectral range and high resolution; X-Light V3 spinning disk confocal enabling dual-camera, high-speed, large FOV imaging; DeepSIM super-resolution module; and VisiView software for integrating and optimizing imaging protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CrestOptics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for S-Biomedic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to S-Biomedic
2.2 - Growth funds investing in similar companies to S-Biomedic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for S-Biomedic
4.2 - Public trading comparable groups for S-Biomedic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →